Koyfin Home > Directory > Health Care > Abeona Therapeutics > Cost of Goods Sold

Abeona Therapeutics Cost of Goods Sold Chart (ABEO)

Abeona Therapeutics annual/quarterly Cost of Goods Sold from 2010 to 2020.
  • Abeona Therapeutics Cost of Goods Sold for the quarter ending June 06, 2020 was $6m a -78.70% decrease of -5m year over year
  • Abeona Therapeutics Cost of Goods Sold for the last 12 months ending June 06, 2020 was $33m a -44.79% decrease of -15m year over year
  • Abeona Therapeutics Annual Cost of Goods Sold for 2019 was $49m a 20.32% increase of 10m from 2018
  • Abeona Therapeutics Annual Cost of Goods Sold for 2018 was $39m a 56.10% increase of 22m from 2017
  • Abeona Therapeutics Annual Cost of Goods Sold for 2017 was $17m a 37.28% increase of 6m from 2016
Other Income Statement Metrics:
  • Abeona Therapeutics EBITDA for the quarter ending September 09, 2018 was $-16m a 47.57% decrease of -8m year over year
  • Abeona Therapeutics Net Income for the quarter ending September 09, 2018 was $-16m a 48.54% decrease of -8m year over year
  • Abeona Therapeutics Total Revenue for the quarter ending September 09, 2018 was $2m a 87.42% increase of 1m year over year
View Chart On Koyfin

Quarterly ABEO Cost of Goods Sold Data

06/2020$6m
03/2020$7m
12/2019$10m
09/2019$11m
06/2019$16m
03/2019$12m
12/2018$9m
09/2018$13m
06/2018$8m
03/2018$8m

Annual ABEO Cost of Goods Sold Data

2019$49m
2018$39m
2017$17m
2016$11m
2013$0m
2012$0m
2011$0m
2010$3m